Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2012

Sep 14, 2012

34117_dirs_2012-09-14_b4196cb4-2cb5-4f51-bbe1-5608072dd4cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-12

Reporting Person: JOHNSON BRUCE F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-12 8% Convertible Debentures Due 2016 $0.092 P Acquired 2016-09-12 Common Stock (1630434) Direct

Footnotes

F1: On September 12, 2012, the reporting person purchased $150,000 principal amount of 8% Convertible Debentures for $150,000 from CopyTele, Inc. in a private placement.